Invion Limited (ASX:IVX)
Australia
· Delayed Price · Currency is AUD 0.1200
+0.0050 (4.35%)
Jun 6, 2025, 3:31 PM AEST
Invion Revenue
Invion had revenue of 1.47M AUD in the twelve months ending December 31, 2024, down -66.59% year-over-year. In the fiscal year ending June 30, 2024, Invion had annual revenue of 3.69M, down -10.00%.
Revenue (ttm)
1.47M
Revenue Growth
-66.59%
P/S Ratio
7.22
Revenue / Employee
366.46K
Employees
4
Market Cap
10.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 3.69M | -410.46K | -10.00% |
| Jun 30, 2023 | 4.10M | 812.95K | 24.70% |
| Jun 30, 2022 | 3.29M | 961.74K | 41.28% |
| Jun 30, 2021 | 2.33M | -1.15M | -32.98% |
| Jun 30, 2020 | 3.48M | -405.31K | -10.44% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Ramsay Health Care | 17.12B |
| Telix Pharmaceuticals | 783.21M |
| Ansell | 3.00B |
| Regis Healthcare | 1.10B |